| 前收市價 | 161.60 |
| 開市 | 160.00 |
| 買盤 | 164.06 x 900 |
| 賣出價 | 164.19 x 900 |
| 今日波幅 | 159.00 - 166.74 |
| 52 週波幅 | 143.13 - 168.85 |
| 成交量 | |
| 平均成交量 | 6,535,470 |
| 市值 | 395.028十億 |
| Beta 值 (5 年，每月) | 0.52 |
| 市盈率 (最近 12 個月) | 24.83 |
| 每股盈利 (最近 12 個月) | 6.61 |
| 業績公佈日 | 2024年10月15日 |
| 遠期股息及收益率 | 4.96 (3.07%) |
| 除息日 | 2024年8月27日 |
| 1 年預測目標價 | 172.74 |
FortuneDeloitte, Johnson & Johnson execs say people aren’t using their health benefits until they are in crisis
At Fortune's MPW Summit, executives explored how companies can bridge the health care gap.
Investor's Business DailyJ&J Stock Leapfrogs 50-Day Line After Health Care Titan Raises Sales Outlook
Johnson & Johnson stock rose Tuesday after the company beat Wall Street's third-quarter expectations, but cut its full-year profit forecast.
ReutersJ&J must pay $15 million to man who says its talc caused his cancer, jury finds
(Reuters) -Johnson & Johnson must pay $15 million to a Connecticut man who alleges that he developed mesothelioma, a rare form of cancer, as a result of using the company's talc powder for decades, a jury found on Tuesday. Plaintiff Evan Plotkin sued the company in 2021 soon after his diagnosis, saying he was sickened by inhaling J&J's baby powder. The jury in Fairfield County, Connecticut Superior Court also found that the company should pay additional punitive damages, which will be determined later by the judge overseeing the case.
